{"id":47972,"date":"2024-01-02T09:57:17","date_gmt":"2024-01-02T08:57:17","guid":{"rendered":"https:\/\/gsk.de\/?p=47972"},"modified":"2024-01-02T09:57:19","modified_gmt":"2024-01-02T08:57:19","slug":"daniel-fehling-joins-gsk-stockmanns-corporate-team","status":"publish","type":"post","link":"https:\/\/gsk.de\/en\/daniel-fehling-joins-gsk-stockmanns-corporate-team\/","title":{"rendered":"Daniel Fehling joins GSK\u00a0Stockmann\u2019s corporate\/M&amp;A team"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>At the turn of the year, GSK Stockmann is welcoming Daniel Fehling to strengthen its Corporate\/M&amp;A practice in Hamburg<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Daniel Fehling (43) will be joining GSK&nbsp;Stockmann\u2019s Hamburg team as an equity partner on 1 January 2024. He has been practising as a lawyer for 13 years and will be joining GSK&nbsp;Stockmann from Luther, where he has been working \u2013 recent years as a partner \u2013 in the corporate\/M&amp;A department for over ten years. Fehling advises (family-owned) businesses, family offices and private equity investors on (cross-border) transactions (M&amp;A, private equity). Daniel Fehling will thus be working closely with GSK Stockmann\u2019s offices in London and Luxembourg. He also advises in all corporate law matters, including restructurings. Fehling is a certified specialist for commercial and corporate law as well as for banking and capital markets law. He holds a Master of Laws (LL.M.) from the University of Auckland, New Zealand.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GSK&nbsp;Stockmann focuses on advising on complex and cross-border transactions structured via Luxembourg and London in the areas of private equity, venture capital and real estate. The firm has taken important steps on this path in recent years with the opening of an office in Luxembourg in 2016 and a representative office in London in 2022. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>\u201cThanks to his M&amp;<\/em>A <em>expertise, Daniel Fehling will help us to further expand the range of advisory services we offer in this area at an international level<\/em>,\u201d comments Managing Partner Oliver Gl\u00fcck on the new hire. <em>\u201cThe continuous growth of our corporate\/M&amp;<\/em>A <em>practice is a reflection of our long-term international strategy<\/em>.\u201d <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In the fourth quarter of 2023, GSK\u00a0Stockmann brought two specialists in the area of corporate\/M&amp;A on board, <a href=\"https:\/\/gsk.de\/en\/new-partner-in-luxembourg-gsk-stockmann-brings-anna-gassner-on-board\/\">Anna Gassner<\/a> in Luxembourg and <a href=\"https:\/\/gsk.de\/en\/robert-korndorfer-joins-gsk-stockmanns-berlin-office-as-a-new-partner\/\">Robert Kornd\u00f6rfer<\/a> in Berlin.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Daniel Fehling (42) will be joining GSK\u00a0Stockmann\u2019s Hamburg team as an equity partner on 1 January 2024. <\/p>\n","protected":false},"author":32,"featured_media":48000,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[404],"tags":[],"ausgabe":[675],"verknuepfung":[763,775],"class_list":["post-47972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firm","ausgabe-gsk","verknuepfung-corporate","verknuepfung-ma-en"],"acf":{"ansprechpartner":[{"anwalt":47939}],"standard_text":true,"custom_text":false,"postdownloads":false,"pressekontakt":{"email":"","phone":""}},"info":{"date":"02.01.2024","author":"GSK Sysop","categories_names":["Law firm"],"category":"Law firm"},"wpml_main_post_id":47965,"featured_img_src":"https:\/\/gsk.de\/wp-content\/uploads\/2024\/01\/Fehling_Daniel_1540x900px_PR-1024x598.jpg","_links":{"self":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/47972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/comments?post=47972"}],"version-history":[{"count":5,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/47972\/revisions"}],"predecessor-version":[{"id":48007,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/posts\/47972\/revisions\/48007"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/media\/48000"}],"wp:attachment":[{"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/media?parent=47972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/categories?post=47972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/tags?post=47972"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/ausgabe?post=47972"},{"taxonomy":"verknuepfung","embeddable":true,"href":"https:\/\/gsk.de\/en\/wp-json\/wp\/v2\/verknuepfung?post=47972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}